Spectrawave, INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$201Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
202clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Charles Simonton | Charlotte, NC | Cardiovascular Disease | $39,512.08 |
| Ryan Madder | Royal Oak, MI | Interventional Cardiology | $25,882.10 |
| Ziad Ali | New York, NY | Internal Medicine | $16,174.61 |
| Tak Kwan | New York, NY | Interventional Cardiology | $15,594.71 |
| Megha Prasad | New York, NY | Cardiovascular Disease | $9,843.50 |
| Morton Kern | Orange, CA | Cardiovascular Disease | $7,848.26 |
| Haroon Faraz | Teaneck, NJ | Interventional Cardiology | $5,457.21 |
| James Muller | Boston, MA | Cardiovascular Disease | $4,753.17 |
| Brian Bergmark | Boston, MA | Cardiovascular Disease | $4,500.00 |
| Paul Teirstein | La Jolla, CA | Interventional Cardiology | $4,286.97 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.